Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Okuno

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Current Treatment Options in Oncology|October 13, 2006
The enigma of desmoid tumorsScott Okuno
Current Opinion in Oncology|May 25, 2006
Mammalian target of rapamycin inhibitors in sarcomasScott Okuno
Spine|October 10, 2009
State of the art management in spine oncology: a worldwide perspective on its evolution, current state, and futureNarayan Sundaresan, Stefano Boriani, Scott Okuno
Journal of Carcinogenesis|June 5, 2019
Immunotherapy in breast cancerSoley Bayraktar, Sameer Batoo, Scott Okuno, et al.
Cancers|November 12, 2013
Current perspectives on desmoid tumors: the mayo clinic approachSiddharth B Joglekar, Peter S Rose, Franklin Sim, et al.
Cancer|July 13, 2002
Phase II trial of gemcitabine in advanced sarcomasScott Okuno, John Edmonson, Michelle Mahoney, et al.
Future Oncology (London, England)|August 18, 2020
Future perspectives and challenges with CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancerSoley Bayraktar, Sameer Batoo, Eyad Al-Hattab, et al.
Gynecologic Oncology Reports|June 16, 2015
Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: A case report and review of the literatureSharon Kim, Jamie N Bakkum-Gamez, Scott Okuno, et al.
Journal of Carcinogenesis|January 18, 2020
Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancerSameer Batoo, Soley Bayraktar, Eyad Al-Hattab, et al.
Neurosurgery|January 14, 2021
Frequent CTNNB1 p.S45 Mutations and Aggressive Clinical Behavior in Neuromuscular Choristoma-Associated FibromatosisJodi M Carter, Andres A Maldonado, B Matthew Howe, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Current Treatment Options in Oncology|October 13, 2006
The enigma of desmoid tumorsScott Okuno
Current Opinion in Oncology|May 25, 2006
Mammalian target of rapamycin inhibitors in sarcomasScott Okuno
Spine|October 10, 2009
State of the art management in spine oncology: a worldwide perspective on its evolution, current state, and futureNarayan Sundaresan, Stefano Boriani, Scott Okuno
Journal of Carcinogenesis|June 5, 2019
Immunotherapy in breast cancerSoley Bayraktar, Sameer Batoo, Scott Okuno, et al.
Cancers|November 12, 2013
Current perspectives on desmoid tumors: the mayo clinic approachSiddharth B Joglekar, Peter S Rose, Franklin Sim, et al.
Cancer|July 13, 2002
Phase II trial of gemcitabine in advanced sarcomasScott Okuno, John Edmonson, Michelle Mahoney, et al.
Future Oncology (London, England)|August 18, 2020
Future perspectives and challenges with CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancerSoley Bayraktar, Sameer Batoo, Eyad Al-Hattab, et al.
Gynecologic Oncology Reports|June 16, 2015
Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: A case report and review of the literatureSharon Kim, Jamie N Bakkum-Gamez, Scott Okuno, et al.
Journal of Carcinogenesis|January 18, 2020
Recent advances and optimal management of human epidermal growth factor receptor-2-positive early-stage breast cancerSameer Batoo, Soley Bayraktar, Eyad Al-Hattab, et al.
Neurosurgery|January 14, 2021
Frequent CTNNB1 p.S45 Mutations and Aggressive Clinical Behavior in Neuromuscular Choristoma-Associated FibromatosisJodi M Carter, Andres A Maldonado, B Matthew Howe, et al.
Pageof 4